SEC Filing Analysis: Innoviva, Inc. (INVA)

Executive Summary

• Trading Significance: Medium
• Key Takeaway: A 10% owner, Pavel Raifeld, was granted restricted stock units (RSUs) valued at approximately $2 million as a form of equity compensation.
• Market Impact: The transaction is a routine compensation event and is expected to have a neutral market impact, causing minor shareholder dilution.

Company Information

Field	Value
Company	Innoviva, Inc.
Ticker Symbol	INVA
CIK	0001080014
Industry	Pharmaceutical Preparations

Insider Information

Field	Value
Name	Raifeld Pavel
CIK	0001813426
Title/Position	null
Relationship	10% Owner

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-03
Transaction Code	A (Award)
Security Type	Common Stock (RSU Grant)
Shares Involved	110,436
Price Per Share	$18.11
Total Value	$2,000,001.96
Shares Owned After	162,276
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$2,000,001.96
% of Market Cap	0.174%
Shares Transacted	110,436
% of Shares Outstanding	0.175%
Post-Transaction Ownership	162,276 shares (0.257% of outstanding)
Materiality Assessment	Moderate

Impact Evaluation

• Market Cap Context: The $2 million grant is a moderate transaction relative to Innoviva's $1.15 billion market capitalization.
• Ownership Concentration: The grant increases the insider's direct holdings, but his total ownership remains a small fraction (0.257%) of the total shares outstanding.
• Dilution Impact: The issuance of 110,436 new shares represents a minor dilution of approximately 0.175% to existing shareholders, which is not considered material.
• Transaction Significance: The transaction is classified as 'Medium' significance. While the dollar value is substantial, it is an RSU grant (compensation) rather than an open-market purchase, which would be a stronger indicator of insider confidence. The insider's status as a 10% owner adds to the noteworthiness.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Equity grants are a common form of executive and stakeholder compensation and do not typically signal new, non-public information. The market generally anticipates such events.

Volume & Sentiment

• Expected Volume Impact: Minimal. As this is not an open-market transaction, it will not directly impact trading volume.
• Sentiment Indicator: Neutral. The filing confirms a standard compensation practice rather than a bullish or bearish action by the insider.

Investment Insights

Positive Market Indicators

• Aligning insider interests with shareholders through equity compensation is generally seen as a positive governance practice.

Risk Factors

• Equity grants contribute to shareholder dilution over time, although this specific grant has a minimal impact.

Key Takeaways

1. A 10% owner received a significant equity award valued at $2 million.
2. The transaction is a grant, not an open-market buy, indicating it is part of a compensation plan.
3. The financial impact on the company, in terms of shareholder dilution (0.175%), is minor.

Additional Context

Transaction Notes

• Special Circumstances: The filing footnote indicates this is a time-vested Restricted Stock Unit (RSU) grant. Vesting begins on November 20, 2026, and continues quarterly thereafter, contingent on continued service.
• Market Environment: This is a routine corporate action and is not tied to any specific market event.